161 related articles for article (PubMed ID: 33118172)
1. Nulliparity and postmenopausal status are independent factors of malignancy potential of endometrial intraepithelial neoplasia in polyps.
Karakas LA; Atilgan AO; Akilli H; Kuscu UE; Haberal A; Ayhan A
Int J Gynaecol Obstet; 2021 Mar; 152(3):433-438. PubMed ID: 33118172
[TBL] [Abstract][Full Text] [Related]
2. Atypical Endometrial Polyps and Concurrent Endometrial Cancer: A Systematic Review.
de Rijk SR; Steenbergen ME; Nieboer TE; Coppus SF
Obstet Gynecol; 2016 Sep; 128(3):519-525. PubMed ID: 27500332
[TBL] [Abstract][Full Text] [Related]
3. Hysteroscopic resection of symptomatic and asymptomatic endometrial polyps.
Lieng M; Qvigstad E; Sandvik L; Jørgensen H; Langebrekke A; Istre O
J Minim Invasive Gynecol; 2007; 14(2):189-94. PubMed ID: 17368255
[TBL] [Abstract][Full Text] [Related]
4. Risk of malignancies among asymptomatic postmenopausal women with thickened endometrium: A cohort study.
Li Z; Li L
Medicine (Baltimore); 2019 Feb; 98(6):e14464. PubMed ID: 30732213
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen use as a malignancy risk factor in postmenopausal women with endometrial polyps.
Yela DA; Ikejiri TA; Machado CR; Mutta D; Benetti-Pinto CL
Menopause; 2019 Aug; 26(8):863-866. PubMed ID: 30969185
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of malignancy in endometrial polyps during postmenopause.
Mossa B; Torcia F; Avenoso F; Tucci S; Marziani R
Eur J Gynaecol Oncol; 2010; 31(2):165-8. PubMed ID: 20527232
[TBL] [Abstract][Full Text] [Related]
7. Hysterscopic Resection of Premalignant and Malignant Endometrial Polyps: Is it a Safe Alternative to Hysterectomy?
Elyashiv O; Sagiv R; Kerner R; Keidar R; Menczer J; Levy T
J Minim Invasive Gynecol; 2017; 24(7):1200-1203. PubMed ID: 28802955
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors for malignancy in hysteroscopy-resected endometrial polyps.
Wong CLH; So PL
Int J Gynaecol Obstet; 2021 Dec; 155(3):433-441. PubMed ID: 33621356
[TBL] [Abstract][Full Text] [Related]
9. The office hysteroscopic evaluation of postmenopausal patients.
Arslan S; Gökmen O; Tuncay G
Arch Gynecol Obstet; 2004 Jul; 270(1):31-3. PubMed ID: 12955530
[TBL] [Abstract][Full Text] [Related]
10. Outcomes in women age 40 years and older with cytologically benign endometrial cells.
Casey PM; Gallenberg MM; Kastner TM; Barrette BA; Chantigian PD; Shuster LT; MacLaughlin KL; Allensworth SK; Weaver AL
Am J Obstet Gynecol; 2012 Nov; 207(5):379.e1-6. PubMed ID: 22964067
[TBL] [Abstract][Full Text] [Related]
11. Is the finding of endometrial hyperplasia or corporal polyp an mandatory indication for biopsy?
Vinklerová P; Felsinger M; Frydová S; Ovesná P; Hausnerová J; Weinberger V
Ceska Gynekol; 2020; 85(2):84-93. PubMed ID: 32527101
[TBL] [Abstract][Full Text] [Related]
12. Clinical parameters linked with malignancy in endometrial polyps.
Gregoriou O; Konidaris S; Vrachnis N; Bakalianou K; Salakos N; Papadias K; Kondi-Pafiti A; Creatsas G
Climacteric; 2009 Oct; 12(5):454-8. PubMed ID: 19591006
[TBL] [Abstract][Full Text] [Related]
13. Endometrial hyperplasia and carcinoma in endometrial polyps: clinicopathologic and follow-up findings.
Mittal K; Da Costa D
Int J Gynecol Pathol; 2008 Jan; 27(1):45-8. PubMed ID: 18156974
[TBL] [Abstract][Full Text] [Related]
14. Endometrial polyp size and polyp hyperplasia.
Lasmar BP; Lasmar RB
Int J Gynaecol Obstet; 2013 Dec; 123(3):236-9. PubMed ID: 24050479
[TBL] [Abstract][Full Text] [Related]
15. Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia.
Vetter MH; Smith B; Benedict J; Hade EM; Bixel K; Copeland LJ; Cohn DE; Fowler JM; O'Malley D; Salani R; Backes FJ
Am J Obstet Gynecol; 2020 Jan; 222(1):60.e1-60.e7. PubMed ID: 31401259
[TBL] [Abstract][Full Text] [Related]
16. Atypical endometrial polyps and the incidence of endometrial cancer: a retrospective cohort study.
Jacobs I; Tibosch R; Geomini P; Coppus S; Bongers MY; van Hanegem N
BJOG; 2020 Jul; 127(8):994-999. PubMed ID: 32133762
[TBL] [Abstract][Full Text] [Related]
17. Predictors of malignancy in endometrial polyps: study of 421 women with postmenopausal bleeding.
Ghoubara A; Sundar S; Ewies AAA
Climacteric; 2018 Feb; 21(1):82-87. PubMed ID: 29219004
[TBL] [Abstract][Full Text] [Related]
18. Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics.
Costa-Paiva L; Godoy CE; Antunes A; Caseiro JD; Arthuso M; Pinto-Neto AM
Menopause; 2011 Dec; 18(12):1278-82. PubMed ID: 21926931
[TBL] [Abstract][Full Text] [Related]
19. Endometrial polyp or neoplasia? A case-control study in women with polyps at ultrasound.
Gambadauro P; Martínez-Maestre MÁ; Schneider J; Torrejón R
Climacteric; 2015 Jun; 18(3):399-404. PubMed ID: 25333383
[TBL] [Abstract][Full Text] [Related]
20. Can malignant potential of endometrial polyps be determined by incorporating the endometrial intraepithelial neoplasia (EIN) classification?
Naaman Y; Diment J; Perlman S; Oustinov N; Vaisbuch E; Ben-Arie A
Gynecol Oncol; 2015 Feb; 136(2):254-7. PubMed ID: 25524459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
